RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP

Regen BioPharma Inc

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026

$0.00+0.00 (+50.00%)

Close on Oct 19, 2026

Community

Notes and questions about Regen BioPharma from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Regen BioPharma's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Feb 10, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is RGBP.

Advertisement
300 × 250